"Pertussis Toxin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the virulence factors produced by BORDETELLA PERTUSSIS. It is a multimeric protein composed of five subunits S1 - S5. S1 contains mono ADPribose transferase activity.
| Descriptor ID |
D037342
|
| MeSH Number(s) |
D08.811.913.400.725.115.680 D23.946.123.946.690 D23.946.896.980.690
|
| Concept/Terms |
Pertussis Toxin- Pertussis Toxin
- Toxin, Pertussis
- Lymphocytosis-Promoting Factor
- Lymphocytosis Promoting Factor
- Islet-Activating Protein
- Islet Activating Protein
- Histamine-Sensitizing Factor
- Histamine Sensitizing Factor
- IAP Pertussis Toxin
- Pertussis Toxin, IAP
- Toxin, IAP Pertussis
- Islets-Activating Protein
- Islets Activating Protein
- Pertussigen
|
Below are MeSH descriptors whose meaning is more general than "Pertussis Toxin".
Below are MeSH descriptors whose meaning is more specific than "Pertussis Toxin".
This graph shows the total number of publications written about "Pertussis Toxin" by people in this website by year, and whether "Pertussis Toxin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 2 | 3 |
| 1998 | 0 | 5 | 5 |
| 1999 | 0 | 3 | 3 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 2 | 3 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2018 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pertussis Toxin" by people in Profiles.
-
Intranasal sensitization model of alopecia areata using pertussis toxin as adjuvant. Front Immunol. 2024; 15:1469424.
-
Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination During Pregnancy: Impact on Infant Anti-Pertussis Antibody Concentrations by Maternal Pertussis Priming Series. Clin Infect Dis. 2023 02 08; 76(3):e1087-e1093.
-
Association Between Third-Trimester Tdap Immunization and Neonatal Pertussis Antibody Concentration. JAMA. 2018 10 09; 320(14):1464-1470.
-
Identification of a GaG??, AKT and PKCa signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition. Int J Oncol. 2012 Jul; 41(1):189-200.
-
Expression pattern and signalling pathways in neutrophil like HL-60 cells after treatment with estrogen receptor selective ligands. Mol Cell Endocrinol. 2012 Sep 25; 361(1-2):179-90.
-
Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury. Am J Physiol Heart Circ Physiol. 2011 Oct; 301(4):H1487-95.
-
Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development. Mol Biol Rep. 2011 Mar; 38(3):1957-63.
-
Differential activation of eosinophils by 'probiotic' Bifidobacterium bifidum and 'pathogenic' Clostridium difficile. Int Arch Allergy Immunol. 2010; 152 Suppl 1:83-9.
-
FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling. J Mol Cell Cardiol. 2010 Feb; 48(2):406-14.
-
Control of glycinergic input to spinal dorsal horn neurons by distinct muscarinic receptor subtypes revealed using knockout mice. J Pharmacol Exp Ther. 2007 Dec; 323(3):963-71.